Indo US Bio-Tech standalone net profit rises 48.26% in the June 2025 quarter
Sales rise 24.47% to Rs 30.77 crore
Net profit of Indo US Bio-Tech rose 48.26% to Rs 4.70 crore in the quarter ended June 2025 as against Rs 3.17 crore during the previous quarter ended June 2024. Sales rose 24.47% to Rs 30.77 crore in the quarter ended June 2025 as against Rs 24.72 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales30.7724.72 24 OPM %17.7814.93 -PBDT5.023.39 48 PBT4.823.19 51 NP4.703.17 48Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 12 2025 | 4:30 PM IST